Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
How do you manage HPV positive squamous cell carcinoma in situ of the oropharynx?
Answer from: Radiation Oncologist at Academic Institution
transoral surgery
Sign in or Register to read more
3210
Related Questions
What dose and regimen would you treat a stage I laryngeal cancer s/p R1 resection?
Would you consider palliative RT in the setting of tumor causing osteonecrosis in an elderly patient?
How do you advise a patient on ozone therapy?
Is there a role for reirradiation for SCC oral tongue with high-risk features (i.e., PNI, close margins) following surgery?
How would you manage an early stage HPV mediated pure adenocarcinoma of the tonsil with a large but resectable primary and multiple ipsilateral nodes without clear ECE on imaging?
What is the recommended adjuvant dose for neuroendocrine cancer in the head and neck?
Are there any special treatment considerations when treating a patient with laryngeal cancer with significant Reinke's edema of the vocal folds?
What dose/fractionation would you use for a multiply recurrent and now unresectable ameloblastoma involving the masticator space, pterygopalatine fossa, and right maxillary sinus?
What changes do you make in the management of non-endemic nasopharynx cancer compared to endemic?
In oral cavity cancers, how does WPOI (worse pattern of invasion) influence your decision to offer adjuvant therapy?